Fresh Rounds

Cantai Therapeutics, Inc. funding

Cantai Therapeutics, Inc., a biotechnology company based in Philadelpia, PA (founded 2023), filed a Form D with the SEC on January 21, 2026 and reported $3M raised.

Amount raised$3M
Offering size$3M
Filed with the SECJanuary 21, 2026
First saleJanuary 15, 2026
IndustryBiotechnology
SecuritiesEquity
LocationPhiladelpia, PA
Founded2023
Entity typeCorporation
Investors so far3
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Pennsylvania